These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 25756694)
1. Hormone therapy and risk of all-cause mortality in women treated with statins. Hodis HN; Mack WJ Menopause; 2015 Apr; 22(4):363-4. PubMed ID: 25756694 [No Abstract] [Full Text] [Related]
2. Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins. Berglind IA; Andersen M; Citarella A; Linder M; Sundström A; Kieler H Menopause; 2015 Apr; 22(4):369-76. PubMed ID: 25335101 [TBL] [Abstract][Full Text] [Related]
3. Statins for primary prevention of coronary artery disease. McPherson R; Kavaslar N Lancet; 2007 Mar; 369(9567):1078; author reply 1079. PubMed ID: 17398299 [No Abstract] [Full Text] [Related]
4. The statins in preventive cardiology. Steinberg D N Engl J Med; 2008 Oct; 359(14):1426-7. PubMed ID: 18832243 [No Abstract] [Full Text] [Related]
6. BMS consensus statement for primary prevention of coronary heart disease in women. Stevenson JC Post Reprod Health; 2019 Jun; 25(2):64-69. PubMed ID: 31192759 [No Abstract] [Full Text] [Related]
7. Continuation of statin treatment and mortality: a note of caution on excessive benefits. Filion KB; Schneider-Lindner V; Karp I; Lévesque LE; Brophy JM; Suissa S Arch Intern Med; 2009 Jun; 169(11):1080; author reply 1080-1. PubMed ID: 19506187 [No Abstract] [Full Text] [Related]
8. The statins in preventive cardiology. Newman DH N Engl J Med; 2009 Jan; 360(5):541; author reply 541-2. PubMed ID: 19179327 [No Abstract] [Full Text] [Related]
9. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Cheung BM; Lauder IJ; Lau CP; Kumana CR Br J Clin Pharmacol; 2004 May; 57(5):640-51. PubMed ID: 15089818 [TBL] [Abstract][Full Text] [Related]
10. [Statins with hormone replacement therapy in postmenopausal women with low bone mineral density]. Shintani M Nihon Rinsho; 2004 Feb; 62 Suppl 2():488-91. PubMed ID: 15035177 [No Abstract] [Full Text] [Related]
11. Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism. Maitland-van der Zee AH; Klungel OH; Leufkens HG; de Boer A; Stricker BH; Hofman A; Witteman JC; van Duijn CM; Kastelein JJ Atherosclerosis; 2004 Aug; 175(2):377-9. PubMed ID: 15262195 [No Abstract] [Full Text] [Related]
12. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Ray KK; Seshasai SR; Erqou S; Sever P; Jukema JW; Ford I; Sattar N Arch Intern Med; 2010 Jun; 170(12):1024-31. PubMed ID: 20585067 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of dyslipidemia in postmenopausal women: weighing the evidence. Brophy DF; Crouch MA; Ruffin DM; Wazny LD; McKenney JM J Womens Health Gend Based Med; 1999 Sep; 8(7):901-17. PubMed ID: 10534293 [TBL] [Abstract][Full Text] [Related]
14. Statins and risk of coronary heart disease. Ebrahim S; Smith GD JAMA; 2000 Jun; 283(22):2935-6. PubMed ID: 10865267 [No Abstract] [Full Text] [Related]